2026 NPPES data Primary Podiatric Medicine Podiatrist NPI 1033143359 D.P.M.
Verify on CMS →

MELINEH ASLANIAN, D.P.M.

Primary Podiatric Medicine Podiatrist in GLENDALE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 279 beneficiaries · Primary Podiatric Medicine Podiatrist avg: 322
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$181.33
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MELINEH ASLANIAN, D.P.M. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 1,054 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
1K
Part D claims, 2023
93%
generic prescribing
$181.33
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MELINEH ASLANIAN, D.P.M.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MELINEH ASLANIAN, D.P.M.?

Below national average

NPI registry status

Active

Issued 07/11/2006

NPI 1033143359

Primary specialty

Primary Podiatric Medicine Podiatrist

Niche

1,077 US NPIs in this specialty

Medicare Part D claims

1,054 227% vs specialty avg

2023 prescription claims

Specialty avg: 322

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Primary Podiatric Medicine Podiatrist compares to other specialties among California providers

California providers

Primary Podiatric Medicine Podiatrist share within California

1. Primary Podiatric Medicine Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Primary Podiatric Medicine Podiatrist share within California

Medicare quality performance — MIPS

MELINEH ASLANIAN, D.P.M.'s 2023 MIPS final score plotted against the Primary Podiatric Medicine Podiatrist national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Primary Podiatric Medicine Podiatrist) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Primary Podiatric Medicine Podiatrist) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MELINEH ASLANIAN, D.P.M. appears in the CMS NPPES registry as a Primary Podiatric Medicine Podiatrist provider holding D.P.M. credentials at 125 E GLENOAKS BLVD STE 104, GLENDALE, CA, 91207, with a listed phone of (818) 500-0267. NPI 1033143359 was issued on 07/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ASLANIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,054 prescription claims written by this provider, covering 279 Medicare beneficiaries and totaling roughly $46K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 1.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Primary Podiatric Medicine Podiatrist is a narrow specialty nationwide, with 1,077 enrolled providers across 50 states and an average of 322 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

125 E GLENOAKS BLVD STE 104
GLENDALE, CA 91207

Provider Details

NPI 1033143359
Specialty Primary Podiatric Medicine Podiatrist
Credentials D.P.M.
Gender Female
NPI Issued 07/11/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MELINEH ASLANIAN, D.P.M.. Source: openpaymentsdata.cms.gov.

Total received

$181

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MELINEH ASLANIAN, D.P.M.. To verify MELINEH ASLANIAN, D.P.M.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MELINEH ASLANIAN, D.P.M. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 1,054 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,054
Total Claims
$46K
Total Drug Cost
279
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,223
Total Day Supply
32,959
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$22K
Generic Drug Cost
$24K
Opioid Claims
17 (1.6% rate)
Antibiotic Claims
72

Patient Demographics

Average Patient Age
76.5 years
Avg HCC Risk Score
1.70
Gender Split
63% female / 37% male
Age Distribution
<65: 16, 65-74: 103, 75-84: 108, 85+: 52

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MELINEH ASLANIAN, D.P.M. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
238
Diclofenac Sodium
96
Gabapentin
87
Mupirocin
72
Ammonium Lactate
67
Triamcinolone Acetonide
61
Clotrimazole
37
Ropinirole Hcl
30
Ciprofloxacin Hcl
27
Ssd
Silver Sulfadiazine
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Primary Podiatric Medicine Podiatrist Overview

How MELINEH ASLANIAN, D.P.M. fits within the Primary Podiatric Medicine Podiatrist landscape nationally.

1,077
Primary Podiatric Medicine Podiatrist Providers in US
50
States with Primary Podiatric Medicine Podiatrist
322
Avg Claims per Provider

MELINEH ASLANIAN, D.P.M.'s 1,054 claims are above the specialty average of 322.

Nearby Primary Podiatric Medicine Podiatrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ASLANIAN.

Compare Primary Podiatric Medicine Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MELINEH ASLANIAN, D.P.M.'s specialty?
MELINEH ASLANIAN, D.P.M. specializes in Primary Podiatric Medicine Podiatrist and practices in GLENDALE, California. Credentials: D.P.M..
How much does MELINEH ASLANIAN, D.P.M. prescribe under Medicare Part D?
In 2023, MELINEH ASLANIAN, D.P.M. wrote 1,054 Medicare Part D claims totaling $46K in drug costs for 279 beneficiaries.
What is MELINEH ASLANIAN, D.P.M.'s Medicare quality score?
MELINEH ASLANIAN, D.P.M. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MELINEH ASLANIAN, D.P.M. located?
MELINEH ASLANIAN, D.P.M. is located at 125 E GLENOAKS BLVD STE 104, GLENDALE, CA, 91207. Phone: (818) 500-0267.
What is MELINEH ASLANIAN, D.P.M.'s NPI number?
MELINEH ASLANIAN, D.P.M.'s National Provider Identifier (NPI) is 1033143359, issued on 07/11/2006.
Does MELINEH ASLANIAN, D.P.M. prescribe more brand-name or generic drugs?
MELINEH ASLANIAN, D.P.M.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $22K in brand drug costs.
Does MELINEH ASLANIAN, D.P.M. prescribe opioids?
Yes, MELINEH ASLANIAN, D.P.M. had 17 opioid claims in 2023 with an opioid prescribing rate of 1.6%.
How many Primary Podiatric Medicine Podiatrist providers are there in the US?
There are 1,077 Primary Podiatric Medicine Podiatrist providers across 50 states in the US. The average Primary Podiatric Medicine Podiatrist provider writes 322 Medicare Part D claims per year.
What drugs does MELINEH ASLANIAN, D.P.M. prescribe most often?
Based on 2023 Medicare Part D data, MELINEH ASLANIAN, D.P.M.'s most frequently prescribed drugs include Ketoconazole, Diclofenac Sodium, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MELINEH ASLANIAN, D.P.M. accept Medicare?
MELINEH ASLANIAN, D.P.M. appears in CMS Medicare data with 1,054 Part D claims and 279 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MELINEH ASLANIAN, D.P.M.'s credentials?
MELINEH ASLANIAN, D.P.M.'s NPI is 1033143359 with credentials D.P.M.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology